Dr. Holz came to NYMC from Stern College of Yeshiva University where she served as the Doris and Dr. Ira Kukin Chair in Biology, chair of the Division of Natural Sciences and Mathematics, and holder of a joint appointment in the Department of Molecular Pharmacology of the Albert Einstein College of Medicine. She received her B.Sc. in microbiology and immunology with Great Distinction from McGill University and completed her Ph.D. in cell and developmental biology at Harvard Medical School. Dr. Holz began her tenure on September 1, 2018.
Bringing to NYMC her passion and leadership in biomedical research and education, Dr. Holz leads an NIH-funded laboratory studying the mechanisms of signaling by hormones and growth factors in breast cancer and lymphangioleiomyomatosis (LAM)—a rare lung disease. Her work spans basic science and clinical applications, and has been published in leading journals. The Holz lab has been previously funded by grants from the American Cancer Society (ACS), LAM Foundation, Wendy Will Case Cancer Fund, American Association for Cancer Research (AACR), Mindlin Foundation, National Cancer Center, and Atol Foundation. Dr. Holz also serves as a peer reviewer for multiple journals and participates in grant review study sections for the NIH, Department of Defense, ACS, LAM Foundation, and many international funding agencies.